NASDAQ: SONNSonnet Biotherapeutics Holdings Revenue
Sonnet Biotherapeutics Holdings revenue was $1.00M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, SONN annual revenue was $18.6k, with -87.4% growth year-over-year.
SONN past revenue growth
How has SONN's revenue growth performed historically?
Company
1,689.52%
Industry
150.55%
Market
20.43%
SONN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SONN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SONN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
SONN revenue history
Current Revenue
$1.0M
Current Earnings
-$13.6M
Current Profit Margin
-1,355.6%
Be the first to know when SONN announces revenue.
SONN Revenue History By Year
| SONN Yearly Revenue | SONN Revenue | SONN Change | SONN Revenue Growth |
|---|---|---|---|
| 2024-09-30 | $18.63k | -$129.18k | -87.40% |
| 2023-09-30 | $147.81k | -$202.14k | -57.76% |
| 2022-09-30 | $349.94k | -$133.68k | -27.64% |
| 2021-09-30 | $483.63k | N/A | N/A |
| 2020-09-30 | $0.00 | N/A | N/A |
| 2019-09-30 | $0.00 | -$30.73M | -100.00% |
| 2018-12-31 | $30.73M | -$10.70M | -25.82% |
| 2017-12-31 | $41.43M | -$269.14k | -0.65% |
| 2016-12-31 | $41.70M | $6.35M | +17.96% |
| 2015-12-31 | $35.35M | $5.51M | +18.46% |
| 2014-12-31 | $29.84M | $21.60M | +261.85% |
| 2013-12-31 | $8.25M | $1.40M | +20.36% |
| 2012-12-31 | $6.85M | $5.38M | +364.05% |
| 2011-12-31 | $1.48M | $1.34M | +983.37% |
| 2010-12-31 | $136.30k | -$466.68k | -77.40% |
| 2009-12-31 | $602.98k | $368.92k | +157.62% |
| 2008-12-31 | $234.06k | -$297.19k | -55.94% |
| 2007-12-31 | $531.25k | $404.00k | +317.51% |
| 2006-12-31 | $127.24k | $122.45k | +2,552.00% |
| 2005-12-31 | $4.80k | N/A | N/A |
| 2004-12-31 | $0.00 | N/A | N/A |
Sonnet Biotherapeutics Holdings Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.